CRISPR Therapeutics AG - 48 Year Dividend History | CRSP

Historical dividend payout and yield for CRISPR Therapeutics AG (CRSP) since 1971. The current TTM dividend payout for CRISPR Therapeutics AG (CRSP) as of June 18, 2019 is $0.00. The current dividend yield for CRISPR Therapeutics AG as of June 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.490B $0.003B
CRISPR Therapeutics AG is a gene-editing company. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $108.806B 12.30
Gilead Sciences (GILD) United States $85.546B 10.39
Bio-Techne Corp (TECH) United States $7.848B 53.55